Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News PharmaCyte Biotech Inc PMCB

Healthcare Biotechnology
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including... see more

Current News (NDAQ:PMCB)

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Business Wire November 25, 2025

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Business Wire September 2, 2025

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

Business Wire August 20, 2025

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Business Wire August 18, 2025

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Business Wire May 21, 2024

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.

Business Wire November 15, 2023

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

GlobeNewswire November 15, 2023

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

Business Wire October 31, 2023

PharmaCyte Biotech Announces Final Results of Tender Offer

Business Wire June 15, 2023
View More News ››

Opinion & Analysis (NDAQ:PMCB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PMCB)

PMCB.....Crash Boom Bang.....Rug Pull....Lol

Buy hold & Prosper....$1.25
Iseneschal - December 5, 2025

PMCB....LMFBO....Looks like it's happening...N.H.O.D

And right when I was posting my last Post N.H.O.D ....$1.51
Iseneschal - December 5, 2025

PMCB.....If u took some time to DD this....

and the info I've presented....you would have read that the Capital Raise last August was a Conv PFRD which raised $7,000,000.00...
Iseneschal - December 5, 2025

PMCB.....N.H.O.D $1.45

So far so good
Iseneschal - December 5, 2025

RE:PMCB.....Rumor has it that they own QCLS shs

QCLS has gone thru a NC & RS....used to be TNFA....Here is PMCB's NR ...   PharmaCyte Biotech, Inc. Increases Stake...
Iseneschal - December 5, 2025

PMCB.....Rumor has it that they own QCLS shs

Looks like they do
Iseneschal - December 5, 2025
View more Bullboard ››

Viridian Metals Inc.

Viridian Metals Inc.

Viridian Metals Inc. is a Canadian company engaged in generative exploration for critical metals, with a primary focus on ...
View More »

Podcasts